Allergan, Actavis Near Cash-and-stock Deal: WSJ

Botox maker Allergan Inc. and Irish pharmaceutical company Actavis PLC are close to a friendly deal, which could be announced as early as Monday, the Wall Street Journal reported Sunday. An agreement between the two could fend off Allergan's months-long attempt to thwart a hostile $53 billion bid by Valeant Pharmaceuticals International and activist investor Bill Ackman, the Journal reported, adding Valeant has entertained boosting the offer price.